ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2233

Hip Fracture Incidence in a Teaching Hospital: Intervention for the Prevention of Second Hip Fracture

Xavier González-Giménez1, Carmen Gomez-Vaquero 2, Lidia Valencia-Muntala 3, Andrea Zacarias 1, Irene Martin 4, Carles Tramunt 5 and Ana-Belen Redondo 6, 1Hospital Universitari de Bellvitge. Rheumatology Department, Barcelona, Spain, 2Hospital Universitari de Bellvitge. Rheumatology Department, El Prat, Spain, 3Hospital Universitari de Bellvitge. Rheumatology Department, Cervello, Spain, 4Hospital General Mateu Orfila. Rheumatology Department, Mao, Spain, 5Hospital Universitari de Bellvitge. Orthopaedics Surgery Department, Barcelona, Spain, 6Hospital Universitari de Bellvitge. Technical Secretary, Barcelona, Spain

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Femur Fractures, Recurrent fracture and osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Since March 2009, every patient who was admitted in the Orthopaedic Surgery Department for a hip fracture (HF) was evaluated during the admission period by a Hip Fracture Unit (HFU). The assessment included the risk of fracture and diseases related to bone fragility other than osteoporosis. In the discharge report, a mention of the risk of fracture and the previous treatments as well as a treatment recommendation were done. An electronic prescription was made for the advised treatment. An appointment in the next 3 months in the HFU outpatient clinics was set to monitor treatment adherence.

Purpose: To evaluate the incidence of HF in an 18 year period and the efficacy of the intervention made by the HFU in the incidence of second hip fracture (SHF).

Methods: Methods: From the area hospital discharge database of a teaching hospital between 1st of January of 2000 and 31st of December of 2017, the admissions for HF and SHF from the patients that lived in the reference area of the hospital were analyzed. A SHF was defined as the contralateral HF to a previous HF. SHF were only included if data from the previous HF was available. Two periods of study about 9 years long each were defined: a control period and an intervention period, before and after 1st of March 2009, the date when HFU started working. The rest of the items of the study were: sex, age, age at the time of HF and time of follow-up until SHF or the end of the study. Data about the reference population were accessible in the website of IDESCAT (Catalonian Institute of Statistics: http://www.idescat.cat/pub/). During the period of study, the subjects older than 65 years increased a 33%, from 48,606 to 64,396 inhabitants (31% women, 35% men).

Results: Results: During the 18 years of the study, there were 2,625 patients > 65 years old admitted because of a HF (1,952 women and 673 men, ratio 2.9:1). The annual incidence of HF in this period was 257 fractures for 100,000 inhabitants and year (x 100 K/y) (333 x 100 K/y in women and 154 x 100 K/y in men).

The absolute number of hip fractures increased during the study period in women and in men with significant statistical difference (p < 0.05 women, p < 0.001 men). The incidence of HF has been stable in women and has increased in men (p < 0.05).

The patients included in both study periods were different in age and sex: in the intervention period there were more men (29% vs. 26%, p < 0.05) and they were older (83 ± 7 years, p < 0.001).

In the study period, 133 SHF were admitted (5.06% of fractures). There were 87 SHF which took place in the 1,143 patients who presented a HF during the control period (7.61%) and 46 in the 1,313 (3.50%) during the intervention period (p: ns). There were 244 patients who died during the admission and were excluded from the SHF study.

There were no differences in sex between patients who presented a SHF or those who did not. Patients with SHF were older than patients without SHF (86 ± 7 years vs. 83 ± 7 years, p < 0.001).

Conclusion:

Conclusions: In a teaching hospital, the incidence of HF has remained stable in the last 18 years in women and has increased in men. After 9 years of a HFU intervention, we could not demonstrate a reduction in the incidence of SHF.


Disclosure: X. González-Giménez, None; C. Gomez-Vaquero, None; L. Valencia-Muntala, None; A. Zacarias, None; I. Martin, None; C. Tramunt, None; A. Redondo, None.

To cite this abstract in AMA style:

González-Giménez X, Gomez-Vaquero C, Valencia-Muntala L, Zacarias A, Martin I, Tramunt C, Redondo A. Hip Fracture Incidence in a Teaching Hospital: Intervention for the Prevention of Second Hip Fracture [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/hip-fracture-incidence-in-a-teaching-hospital-intervention-for-the-prevention-of-second-hip-fracture/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hip-fracture-incidence-in-a-teaching-hospital-intervention-for-the-prevention-of-second-hip-fracture/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology